Ocrevus Zunovo 50242-0554-01
Generic: Ocrelizumab And Hyaluronidase
- Manufacturer
- Genentech, Inc.
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- September 13, 2024
- Listing Expires
- December 31, 2027
- Application
- BLA761371
Need to source Ocrevus Zunovo? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Hyaluronidase (human Recombinant) | 23000 U/23mL |
| Ocrelizumab | 920 mg/23mL |
Drug Class
Endoglycosidase [EPC]CD20-directed Cytolytic Antibody [EPC]Antibodies
Selected Package
50242-0554-01Selected1 VIAL, SINGLE-USE in 1 CARTON (50242-554-01) / 23 mL in 1 VIAL, SINGLE-USE
Other packages for this product(1)
1 VIAL, SINGLE-USE in 1 CARTON (50242-554-86) / 23 mL in 1 VIAL, SINGLE-USE